A. Bakar, M. R. Nagy, Z. K. Saleemi, A. N. Rielly, and C. D. , The impact of direct nucleation control on crystal size distribution in pharmaceutical crystallization processes, Crystal Growth and Design, vol.9, issue.3, pp.1378-1384, 2009.

H. A. Akers and D. G. Gabler, The Molar Volume of Solutes in Water, Naturwissenschaften, vol.78, pp.417-419, 1991.

F. H. Allen, The Cambridge Structural Database : a quarter of a million crystal structures and rising, Acta Crystallographica B, vol.58, pp.380-388, 2002.

D. Aquilano and G. Sgualdino, Fundamental aspects of equilibrium and crystallization kinetics in crystallization precoesses in fats and lipid systems, Marcel Dekker, p.1, 2001.

P. M. Armenante and D. J. Kirwan, Mass transfer to microparticules in agitated systems, Chem. Eng. Sci, vol.44, pp.2781-2796, 1989.

S. R. Aubuchon, Detection and Quantification of Amorphous Content in Pharmaceutical Materials, TA Instrument documentation, 2007.

E. Badens, Fluides supercritiques, 2006.

D. Baltès, Cristallisation en fluide supercritique de molécules pharmaceutiques : méthodologie de criblage des polymorphes et étude de la cristallinité des solides formés, 2007.

A. Baronnet, Ostwald ripening in solution. The case of calcite and mica, Estudios geol, vol.38, p.185, 1982.

R. J. Bastin, M. J. Bowker, and B. J. Slater, Salt Selection and Optimisation Procedures for Pharmaceutical New Chemical Entities, Organic Process & Development, vol.4, pp.427-435, 2000.

R. G. Bates, Determination of pH : Theory and practice, 1973.

M. Bauer, Polymorphisme : Descrpition du phénomène, Techniques de l'ingénieur, AF, vol.3, p.640, 2004.

M. Bauer, Physico-chimie du polymorphisme, Techniques de l'ingénieur, AF, vol.3, p.641, 2004.

W. Beckmann, R. Boistelle, and K. Sato, Solubility of the A, B and C polymorphs of stearic acid in decane, methanol, butanone, J. Chem. Eng. Data, vol.29, pp.211-214, 1984.

W. Beckmann, Nucleation phenomena during the crystallisation and precipitation of Abercanil, J. of Crystal Growth, pp.1307-1314, 1999.

W. Beckmann, Seeding the desired polymorph: Background, possibilities, limitations, and case studies, Organic Process Research & Development, vol.4, pp.372-383, 2000.

V. P. Belousov and N. L. Makarova, Heats of mixing of liquids, VIII ethyl alcohol-water, dioxane-water, dioxane-ethyl alcohol binary systems, Vestn. Leningrad Univ. Fiz. Khim, vol.25, pp.101-107, 1970.

S. M. Berge, L. D. Bighley, and C. M. Monkhouse, Pharmaceutical Salts, Journal of Pharmaceutical Sciences, vol.66, issue.1, 1977.

S. N. Black, E. A. Collier, R. J. Davey, and R. J. Roberts, Structure, Solubility, Screening, and Synthesis of Molecular Salts, Journal of Pharmaceutical Sciences, vol.96, pp.1053-1068, 2007.

N. W. Blacow, A. Wade, and . Martindale, Concepts de la cristallisation en solution, The extra Pharmacopoeia, 1973.

R. Boistelle, J. P. Klein, and A. M. Guyot-hermann, Eléments de cristallographie et de cristallogenèse à l'usage des industriels de la chimie et de la pharmacie, S.T.P. Pharma Pratiques, vol.6, issue.2, pp.111-140, 1996.

G. M. Bollas, C. Chen, and P. I. Barton, Refined Electrolyte-NRTL Model: Activity Coefficient Expressions for Application to Multi-Electrolyte Systems, AIChE Journal, vol.54, issue.6, 2008.

V. Boton, P. Lehmann, R. Bolcato, and R. Moreau, Measurement of solute diffusivities. Part III. From solutal convection dominated transport to quasi-diffusive transport, Int. J. of Heat and Mass Transfer, vol.47, pp.2457-2467, 2004.

P. Bordet and P. Deniard, Affinement de diagrammes de diffraction de poudres par la méthode de Rietveld, 18 ème Formation à l'IMN Jean Rouxel, 2009.

P. Bordet and P. Deniard, Détermination structurale ab inition à partir de diagrammes de diffraction de poudres, 18 ème Formation à l'IMN Jean Rouxel, 2009.

F. Bouchet, Symétrie dans les cristaux, Formation permanente : diffraction par les matériaux polycristallins, 2009.

J. Brisset, A. Addou, M. Draoui, D. Moussa, and F. Abdelmalek, Chimie analytique en solution, Editions Lavoisier, 2005.

H. Britt, . Chau-chyun-chen, V. Mahalec, and A. Mcbrien, Modeling and simulation in 2004: an industrial perspective, Foundations of Computer Aided Process Design Proceedings, 2004.

A. Burger and R. Ramberger, On the polymorphism of pharmaceutials and other molecules crystals ii, applicability of thermodynamic rules, pp.259-271, 1979.

J. Burgot, Chimie analytique et équilibres ioniques, 2006.

W. K. Burton, N. Cabrera, and F. C. Franck, The growth of the crystals and the equilibrium structure of their surfaces, Phil. Trans. Royal Soc, pp.299-358, 1951.

A. Caillet, Etude de la transition de phase en solution d'un hydrate grâce à un suivi in situ par spectroscopie Raman et acquisition d'images, 2006.

R. Chareyron, Méthodes d'analyse thermique, Cours CPE Lyon, 2003.

G. Charlot and B. Trémillon, Les réactions chimiques dans les solvants et les sels fondus, Editions Gauthiers Villard, 1963.

C. Chen and Y. Song, Solubility Modelling with a Nonrandom Two-Liquid Segment Activity Coefficient Model, Ind. Eng. Chem. Res, vol.43, pp.8354-8362, 2004.

C. Chen and Y. Song, Extension of Nonorandom Two-Liquid Segment Activity Coefficient Model for Electrolyte, Ind. Eng. Chem. Res, vol.44, pp.8909-8921, 2005.

C. Chen and P. A. Crafts, Correlation and Prediction of Drug Molecule Solubility in Mixed Solvent Systems with the Nonrandom Two-Liquid Segment Activity Coefficient (NRTL-SAC) Model, Ind. Eng. Chem. Res, vol.45, pp.4816-4824, 2006.

C. Chen, Toward development of activity coefficient models for process and product design of complex chemical systems, Fluid Phase Equilibria, pp.103-112, 2006.

S. R. Chemburkar, J. Bauer, K. Deming, H. Spiwek, and K. Patel,

J. Morris, R. Henry, S. Spanton, W. Dziki, W. Porter et al., Dealing with the impact of Ritonavir Polymorphs on the Late Stages of Bulk Drug Process Development, Organic Process Research & Development, vol.4, pp.413-417, 2000.

A. A. Chernov, Modern crystallography III, part. I, 1984.

D. Cosserat and . Développement-pharmaceutique, Cours CPE Lyon, 2003.

P. Crafts, Crystallisation Process Development in the Pharmaceutical Sector, CAPEC AGM, présentation AstraZeneca, 2005.

R. J. Davey, L. A. Polywka, and S. J. Maginn, The control of crystal morphology by additives : molecular recognition, kinetic and technology, in advances in industrial crystallization, Butterworth Heinemann, p.150, 1991.

R. J. Davey, N. Bladhen, S. Righini, H. Alison, and E. S. Ferrari, Nucleation control in solution mediated polymorphic phase transformations: The case of 2,6dihydroxybenzoic acid, J. Phys. Chem. B, vol.106, pp.1954-1959, 2002.

R. J. Davey, S. N. Black, B. G. Cox, E. Collier, and C. Towler, Crystallisation of Molecular Salts, Proceedings of Isic 16 th, 2005.

D. Jong, E. J. Jancic, and S. J. , The one or the order, Proceedings of 9 th symposium on industrial crystallization, 1984.

M. Delcourt, N. Bois, and F. Chouaib, Equilibres Chimiques en solution, 2001.

P. Deniard, M. Evain, J. M. Barbet, and R. Brec, The INEL X-ray position sensitive detector: A study of D-spacing and exposure time, Materials Science Forum, pp.363-370, 1991.

P. Deniard, Diffraction par les matériaux polycristallins, 18 ème Formation à l'IMN Jean Rouxel, 2009.

T. Detoisien, M. Forite, P. Taulelle, J. Teston, D. Colson et al., A rapid Method for Screening Crystallization Conditions and Phases of an Active Pharmaceutical Ingredient, Organic Process Research & Development, vol.13, pp.1338-1342, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00440719

M. Descamps, J. F. Willart, E. Dudognon, and V. Caron, Transformation of Pharmaceutical Compounds upon Milling and Comilling: The role of Tg, Journal of Pharmaceutical Sciences, vol.95, pp.1398-1407, 2007.

J. A. Dirksen and T. A. Ring, Fundamentals of crystallization: kinetic effects on particle size distributions and morphology, Chem. Eng. Sci, pp.2389-2427, 1991.

J. D. Donnay and D. Harker, A new law of crystal morphology extending the law of Bravais, Amer. Min, vol.22, p.446, 1937.

D. Cuny and L. , Aqueous solubility of Drug-like compounds, 2006.

M. L. Dumas and R. I. Ben-aïm, Réactions ioniques en solution aqueuse, L'indispensable, Bréal Editions, 2003.

A. D. Edwards, B. Y. Shekunov, A. Kordikowski, and R. T. Forbes,

P. York, Crystallization of pure anhydrous polymorphs of carbamazepine by solution enhanced dispersion with supercritical fluids (SEDS), Journal of Pharmaceutical Sciences, vol.90, issue.8, pp.1115-1124, 2001.

F. Espitalier, B. Biscans, P. Sere-peyrigain, and C. Laguérie, Ternary diagram : alpha-(-benzoylphenyl)-propionic acid (ketoprofen) in acetone-water mixtures at different temperatures, Experimental data and predicted results, Fluid Phase Equilibria, vol.113, pp.151-171, 1995.
URL : https://hal.archives-ouvertes.fr/hal-01868133

F. Espitalier, B. Biscans, C. Laguérie, . Particle-design, and A. Part, Nucleation kinetics of ketoprofen, vol.68, pp.95-102, 1997.
URL : https://hal.archives-ouvertes.fr/hal-01868720

R. Faure, . Cristallographie, C. Cours, and . Lyon, , 2003.

O. C. Filho and P. Rasmussen, Modeling of salt solubilities in mixed solvents, Brazilian Journal of Chemical Engineering, vol.17, issue.2, 2000.

E. Gagnière, Etude du procédé de co-cristallisation de molécules d'intérêt pharmaceutique : aspects cinétiques et thermodynamiques, 2009.

E. Garcia, Etude de la dissolution et de la croissance de principes actifs, 2000.

S. Garnier, S. Petit, and G. Coquerel, Influence of supersaturation and structurally related additives on the crystal growth of ?-lactose monohydrate, J. of Crystal Growth, vol.234, p.207, 2002.
URL : https://hal.archives-ouvertes.fr/hal-01936216

D. Giron, P. Remy, S. Thomas, and E. Vilette, Quantification of amorphicity by microcalorimetry, Journal of Thermal Analysis, vol.48, pp.465-472, 1997.

D. Giron, Thermal analysis, Microcalorimetry and Combined Techniques for the Study of Pharmaceuticals, Journal of Thermal Analysis and Calorimetry, vol.56, pp.1285-1304, 1999.

P. L. Gould, Salt Selection for basic drugs, International Journal of Pharmaceutics, vol.33, pp.201-217, 1986.

P. Hartmann, The attachment energy as a habit controlling factor II., application to corundum, J. of Crystal Growth, vol.49, 1980.

G. Herndl and A. B. Mersmann, Fluid dynamics and mass-transfer in stirred suspensions, Chem. Eng. Commun, vol.19, pp.23-27, 1981.

J. H. Hildebrand, The temperature dependance of the solubility of solid nonelectrolytes, Journal of Chemical Physics, vol.20, pp.190-191, 1952.

R. Hilfiker, P. H. Stahl, and B. Sutter, Polymorphisme in the Pharmaceutical industry: Salt Selection, 2006.

C. A. Hirsch, R. J. Messenger, and J. L. Brannon, Fenoprofen : Drug Form Selection and Preformulation Stability Studies, Journal of Pharmaceutical Sciences, vol.67, issue.2, 1978.

O. Johdo, Development of industrial crystallization of doxorubicin hydrochloride that has excellent characteristics as an active pharmaceutical ingredient, VDIBerichte, 1901.

H. P. Jones and R. J. Davey, Crystallization of a Salt of a Weak Organic Acid and Base: Solubility Relations, Supersaturation Control and Polymorphic Behavior, J. Phys. Chem. B, vol.109, pp.5273-5278, 2005.

H. P. Jones, Crystallisation of Polymorphic Organic Salts

D. Kashchiev and G. M. Van-rosmalen, Review: nucleation in solution revisited, Cryst. Res. Technol, pp.555-574, 2003.
DOI : 10.1002/crat.200310070

J. P. Klein and R. Boistelle, Cristallisation : Aspects théoriques, Sciences fondmentales des Techniques de l'ingénieur : traité Génie et Procédés Chimiques J1500, 1989.

B. J. Kline, J. Saenz, N. Stankovic, and M. B. Mitchell, Polymorph and Particle Size Control of PPAR Compounds PF00287586 and AG035029, Organic Process Research & Development, vol.10, pp.203-211, 2006.
DOI : 10.1021/op050176r

M. Kociak, Introduction à la microscopie électronique, Collection SFN, vol.8, pp.61-74, 2007.
DOI : 10.1051/sfn:2007006
URL : http://www.neutron-sciences.org/articles/sfn/pdf/2007/01/sfn2007005.pdf

P. B. Kokitkar and E. Plocharczyk, Modeling Drug Molecule Solubility to Identify Optimal Solvent Systems for Crystallization, Organic Process Research & Development, vol.12, issue.2, pp.249-256, 2008.
DOI : 10.1021/op700130z

S. F. Kramer and G. L. Flynn, Solubility of Organic Hydrochlorides, Journal of Pharmaceutical Sciences, vol.61, pp.1896-1904, 1972.
DOI : 10.1002/jps.2600611203

P. A. Langston and T. F. Jones, Non-spherical 2-dimensional particle size analysis from chord measurements using Bayes' Theorem, Particle & Particle Systems Characterization, vol.18, pp.12-21, 2001.
DOI : 10.1002/1521-4117(200102)18:1<12::aid-ppsc12>3.0.co;2-4

J. A. Larkin, Thermodynamic properties of aqueous non-electrolyte mixtures I. Excess enthalpy for water + ethanol at 298,15 to 383,15 K, J. Chem. Thermodynamics, vol.7, pp.137-148, 1975.

J. Lu, P. Chow, and K. Carpenter, Phase Transitions in Lysozyme Solutions Characterized by Differential Scanning Calorimetry, Progress in Crystal Growth and Characterization of Materials, pp.105-129, 2003.
DOI : 10.1016/s0960-8974(03)90004-0

M. L. Maccalman and K. J. Roberts, The influence of growth environment on the crystallization of nortriptyline hydrochloride, a tricylic antidepressant, Journal of Crystal Growth, vol.128, pp.1218-1224, 1993.

P. Marchal, Procédés de la chaîne du solide humide, Cours CPE Lyon, 2003.

I. Markov, Crystal growth for beginners: fundamentals of nucleation, crystal growth and epitaxy, 1995.
DOI : 10.1142/9789812796899

A. Mersmann, Crystallization technology handbook, Marcel Dekker, 2001.

J. Mesplède, Thermodynamique et matériaux inorganiquesChimie PC, 2000.

, Academia News, vol.4, 2008.

, Les rencontres de l'Analyse Thermique, 2009.

M. J. Millan, C. Mannoury-la-cour, F. Novi, R. Maggio, V. Audinot et al., a preferential Dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent : I. Receptor-binding profile anf funcional actions at G-proteincoupled receptors, Pharmacology and experimental pharmaceutics, vol.901, issue.2, pp.587-599, 2008.

M. J. Millan, P. Svenningsson, C. R. Ashby, M. Hill, M. Egeland et al., a preferential Dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent : II. A neurochemical electrophysiological and behavioral characterization in vivo, Pharmacology and experimental pharmaceutics, vol.324, issue.2, pp.600-611, 2008.

M. J. Millan, F. Loiseau, A. Dekeyne, A. Gobert, G. Flik et al., (3H)-yl]-ethyl]phenylacetamide), a preferential Dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent : III. Actions in models of therapeutic activity and induction of side effects, Pharmacology and experimental pharmaceutics, vol.901, issue.2, pp.1212-1226, 2008.

F. Miomandre, S. Sadki, P. Audebert, and M. Méallet-renault, Electrochimie, des concepts aux applications, Editions Dunod, 2005.

S. Miyazaki, M. Oshiba, and T. Nadai, Unusual Solubility and Dissolution Behavior of Pharmaceutical Hydrochloride Salts in Chloride-Containing Media, International Journal of Pharmaceutics, vol.6, pp.77-85, 1980.

S. Miyazaki, M. Oshiba, and T. Nadai, Precaution on Use of Hydrochloride Salts in Pharmaceutical Formulation, Journal of Pharmaceutical Sciences, vol.70, issue.6, 1981.

O. Monnier, J. Klein, C. Hoff, and B. Ratsimba, Particle size determination by laser reflection : Methodology and problems, Particle and particle systems characterization, vol.13, pp.10-17, 1996.

O. Monnier, The use of FBRM to improve an Isomer Separation process, Lasentec Users Forum, 2001.

O. Monnier, Pseudo polymorph transition: the use of FBRM and PVM, Lasentec Users Forum, 2001.

K. R. Morris, M. G. Fakes, A. B. Thakur, A. W. Newman, A. K. Singh et al.,

D. Perrin, B. Dempsey, and E. P. Serjeant, pK a prediction for organic acids ans bases, 1981.

G. Pfeffer and R. Boistelle, Control of molecular crystals morphology, Trans. IChem E, 74 Part A, p.744, 1996.

B. Presles, J. Debayle, A. Rivoire, J. Pinoli, and G. Fevotte, In situ particle size measurements during crystallization processes using image analysis, Récents progrès en Génie des Procédés, vol.98, 2009.

F. Puel, Procédés de la chaîne solide, Cours CPE Lyon, 2003.

F. Puel, Polymorphisme dans les procédés de formulation, Cours CPE Lyon, 2004.

F. Puel, S. Veesler, and D. Mangin, Cristallisation : Aspects théoriques, Techniques de l'ingénieur, J, vol.2, p.710, 2005.

F. Puel, Polymorphisme dans des procédés chimiques, Formation continue CPE Lyon, 2007.

F. Puel, E. Verdurand, P. Taulelle, C. Bebon, D. Colson et al., Crystallization mechanisms of acicular crystals, J. of Crystal Growth, vol.310, pp.110-115, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00269963

J. F. Remenar, J. M. Macphee, B. K. Larson, V. A. Tyagi, and J. H. Ho,

D. A. Mcilroy, M. B. Hickey, P. B. Shaw, and Ö. Almarsson, Salt Selection and Simultaneous Polymorphism Assessment via High-Throughput Crystallization: The case of Sertraline, Organic Process Research & Development, vol.7, pp.990-996, 2003.

S. Righini, Polymorphic transformation of 2,6-Dihydroxybenzoic acid, 2000.

F. Rived, M. Rosés, and E. Bosch, Dissociation constants of neutral and charged acids in methyl alcohol, The acid strength resolution, Analytica Chimica Acta, vol.374, pp.309-324, 1998.

M. Roustan, Agitation, Mélange, Caractéristiques des mobiles d'agitation, Techniques de l'ingénieur, A, vol.5902, 1991.

R. C. Reid, J. M. Prausnitz, and B. E. Poling, The properties of gases and liquids, 1988.

M. Sacchetti, General Equations for In Situ Salt Screening of Multibasic Drugs in Multiprotic Acids, vol.5, pp.579-582, 2000.

J. Schöll, D. Bonalumi, L. Vicum, and M. Mazzotti, In situ monitoring and modeling of the solvent-mediated polymorphic transformation of L-glutamic acid, Crystal Growth and Design, vol.6, issue.4, pp.881-891, 2006.

D. Schweich, Génie de la réaction chimique, 2001.

A. T. Serajuddin and M. Rosoff, pH-Solubility Profil of Papaverine Hydrochloride and its Relationship to the Dissolution Rate of Sustained-Release Pellets, Journal of Pharmaceutical Sciences, vol.73, issue.9, pp.1203-1298, 1984.

A. T. Serajuddin and C. I. Jarowski, Effect of Diffusion Layer pH and Solubility on the Dissolution Rate of Pharmaceutical Bases and Their Hydrochloride Salts I: Phenazopyridine, Journal of Pharmaceutical Sciences, vol.74, issue.2, 1985.

J. Servier, J. Marseille, . Le-médicament, and . La-vie, Editions Perrin, 2007.

P. H. Stahl and C. G. Wermuth, Handbook of Pharmaceutical Salts, Properties, Selection, and Use, 2002.

W. H. Streng, S. K. Hsi, P. E. Helms, and H. G. Tan, General Treatment oh pH-solubility Profiles of Weak Acids and Bases and the Effects of Different Acids on the Solubility of a Weak Base, Journal of Pharmaceuticals Sciences, vol.73, 1984.

J. E. Tabora, Solubility Prediction and the Design of Crystallization Processes, Document institutionel Merck, 2004.

T. Tähti, M. Louhi-kultanen, and S. Palosaari, 14th International Symposium on Industrial Crystallization, 1999.

V. Tantishaiyakul, Prediction of aqueous solubility of organic salts of diclofenac using PLS and molecular modeling, International Journal of Pharmaceutics, vol.275, pp.133-139, 2004.

P. Taulelle, Etude de l'influence d'ajout d'additifs lors de la cristallisation de molécules pharmaceutiques, 2007.

T. Threlfall, Crystallisation of polymorphs : Thermodynamic Insight into the Role of Solvent, Organic Process Research & Development, vol.4, pp.384-390, 2000.

M. Trifkovic and S. Rohani, Polymorphic Generation through Solvent Selection: Ranitidine Hydrochloride, Organic Process Research & Development, vol.11, pp.138-143, 2007.

S. Troost, Influence of surface-active agents on the crystal growth of sodium triphosphate hexahydrate, J. of Crystal Growth, vol.3, issue.4, p.340, 1968.

H. Tung, J. Tabora, N. Variankaval, D. Bakken, and C. Chen, Predictions of Pharmaceutical Solubility Via NRTL-SAC and COSMO-SAC, Journal of Pharmaceutical Sciences, vol.97, issue.5, pp.1813-1820, 2008.

M. G. Vachon and D. J. Grant, Enthalpy-Entropy compensation in pharmaceutical solids, L'équilibre chimique dans les systèmes gazeux ou dissous à l'état dilué, vol.40, pp.239-302, 1886.

S. Veesler and B. Lefrançois, Enthalpies de dissolution dans l'eau de composés minéraux, 1997.

S. Veesler, N. Ferté, M. Costes, M. Czjzek, and J. Astier, Temperature and pH effect on the polymorphisme of Aprotinin (BPTI) in sodium bromide solutions, Crystal Growth and Design, vol.4, issue.6, pp.1137-1141, 2004.

S. Veesler and F. Puel, Polymorphisme dans les procédés de cristallisation en solution, STP Pharma Pratiques, vol.15, issue.1, 2005.

E. Verdurand, C. Bebon, D. Colson, J. P. Klein, and A. F. Blandin,

J. M. Boussoutrot, Secondary nucleation and growth of organic crystals in industrial crystallization, J. Cryst. Growth, pp.1363-1367, 2005.

, Computational Analysis of Aqueous Drug Solubility-influence of the Solid State, 2006.

I. Weissbuch, L. Leiserowitz, and M. Lahav, Tailor made additives and impurities, Crystallization technology handbook, Marcel Dekker Ed, p.401, 2001.

C. G. Wermuth, The practice of Medicinal Chemistry, 1996.

C. R. Wilke and P. Chang, Correlations of diffusion coefficients in dilute solutions, AIChE J, vol.1, p.264, 1955.

J. Worlitschek, Monitoring modelling and optimization of batch cooling crystallization, Thèse ETH Zürich, 2003.

S. H. Yalkowsky, Solubility and partitioning V : Dependance of solubility on melting point, Journal of Pharmaceutical Sciences, vol.70, issue.8, pp.971-973, 1981.

D. Zbaida, M. Lahav, K. Drauz, G. Knaup, and M. Kottenhahn, A cyclic continuous process for converting conglomerates into optically pure enantiomers by crystallization and dissolution with the assistance of Tailor made polymers, Tetrahedron, vol.56, p.6645, 2000.

J. F. Zemaitis, . Jr, D. M. Clark, M. Rafal, and N. C. Scrivner, Handbook of aqueous electrolyte thermodynamics, Hauteur du volume utile dans un réacteur, 1986.

H. , Enthalpies molaire d'excès [J] dH : Variation enthalpique [J] ?H c : Enthalpie de cristallisation

, ?H diss : Enthalpie molaire de dissolution des cristaux, J.mol-1

, ?H f : Enthalpie de fusion

?. H. , Enthalpie molaire partielle du soluté en solution [J.mol-1 ] ?H * i : Enthalpie molaire partielle apparente de la solution

, ?H solv : Enthalpie molaire de solvatation

?. H. , Enthalpie molaire de vaporisation [J.mol-1 ] I : Force ionique

J. , Densité du flux molaire par diffusion [mol.m-2 .s-1 ] K : Terme constant pour l'équation de De Jong